Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
William Li currently holds 75,000 shares of LEAP THERAPEUTICS, INC. (LPTX), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, William Li has been a net neutral trader of LPTX stock. They have purchased $0 and sold $0 worth of shares.
William Li's most recent insider trade was on Jul 1, 2026, when they sold 75,000 shares at $0.00 per share.
William Li serves as Executive at LEAP THERAPEUTICS, INC. (LPTX). They have executed 3 insider transactions totaling $0 over their tenure at the company.
William Li holds the position of Executive at LEAP THERAPEUTICS, INC., where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 2 years and currently hold a stake valued at $0.
William Li has shown a balanced trading pattern, with $0 in total purchases and $0 in total sales across all transactions. Their most recent activity indicates a balanced approach to trading.
The largest transaction by William Li was on Jul 1, 2026, when they purchased $0 worth of CYPH shares. This transaction involved 75,000 shares at N/A per share.
William Li currently owns 75,000 shares of LEAP THERAPEUTICS, INC. (LPTX), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of William Li's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. William Li has 3 Form 4 filings on record as an insider at LEAP THERAPEUTICS, INC..
Set alerts for William Li and 40,000+ other insiders.